Voyager Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Voyager Therapeutics, Inc. (VYGR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -1.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2025-03-11
- Voyager Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -1.10%, a 320.00% decline from fiscal 2023.
- Voyager Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 0.50%.
- Voyager Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -4.60%.
- Voyager Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was -3.80%, a 176.00% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 6 month as first filed | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | -1.10% 10-K · filed 2025-03-11 | |||
| 2023-12-31 | 0.50% 10-K · filed 2025-03-11 | |||
| 2022-12-31 | -4.60% 10-K · filed 2025-03-11 | |||
| 2021-12-31 | -3.80% 10-K · filed 2024-02-28 | |||
| 2020-12-31 | 5.00% 10-K · filed 2023-03-07 | |||
| 2019-12-31 | -2.20% 10-K · filed 2022-03-08 | |||
| 2018-12-31 | -2.10% 10-K · filed 2021-02-25 | |||
| 2017-12-31 | -4.10% 10-K · filed 2020-03-03 | |||
| 2016-12-31 | -4.00% 10-K · filed 2019-02-26 | |||
| 2015-12-31 | -15.50% 10-K · filed 2018-03-14 | -15.60% 10-K · filed 2016-03-17 | ||
| 2014-12-31 | -5.00% 10-K · filed 2016-03-17 | |||
| 2013-12-31 | -5.00% 10-K · filed 2017-03-15 | -0.70% 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |